C-1498 Syngeneic Model

Synonyms: C1498, C-1498 murine AML cell line

C-1498 is a recognized cancer cell line derived from murine acute myeloid leukemia (AML). It is frequently employed in preclinical studies to investigate AML biology, drug response, and therapeutic interventions. C-1498 cells exhibit key characteristics of human AML, making them valuable for studying the disease. They are commonly used to explore genetic alterations, signaling pathways, immune responses, and drug sensitivity in AML research. The C-1498 cell line serves as an important tool in evaluating the efficacy of different treatment modalities, including chemotherapy, targeted therapies, and immunotherapies. It plays a significant role in advancing our understanding of AML and developing novel strategies for its diagnosis and treatment.

Model Details

Cancer Type: Hematopoietic Cancer
Model Name: C-1498
Mouse Strain: C57BL/6
Treatment Data Available: N/A

C-1498 Growth Curve

C-1498 Syngeneic Model

Growth of subcutaneous C-1498 in C57BL/6 mice (n=5)

Request Additional Syngeneic Model Data


Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.